Health Care & Life Sciences » Biotechnology | Edge Therapeutics Inc.

Edge Therapeutics Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Cost of Goods Sold (COGS) incl. D&A
4.40
31.20
53.10
100.10
182.90
Gross Income
4.40
31.20
53.10
100.10
182.90
SG&A Expense
6,483.90
13,163.00
26,445.70
39,412.00
51,783.70
EBIT
6,488.40
13,194.20
26,498.80
39,512.20
51,966.60
Unusual Expense
854.30
582.40
1,879.80
-
-
Non Operating Income/Expense
-
-
-
163.50
-
Interest Expense
3.40
183.20
816.50
1,203.70
2,180.10
Pretax Income
7,342.10
12,792.10
29,186.10
40,667.00
53,445.90
Income Tax
459.00
590.70
1,107.40
1,846.00
2,586.10
Consolidated Net Income
6,883.10
12,201.40
28,078.60
38,821.00
50,859.80
Net Income
6,883.10
12,201.40
28,078.60
38,821.00
50,859.80
Net Income After Extraordinaries
6,883.10
12,201.40
28,078.60
38,821.00
50,859.80
Net Income Available to Common
7,959.30
13,782.10
32,435.10
38,821.00
50,859.80
EPS (Basic)
0.28
0.48
4.01
1.34
1.67
Basic Shares Outstanding
28,593.70
28,593.70
8,087.90
28,864.20
30,394.00
EPS (Diluted)
0.28
0.48
4.01
1.34
1.67
Diluted Shares Outstanding
28,593.70
28,593.70
8,087.90
28,864.20
30,394.00
EBITDA
6,483.90
13,163.00
26,445.70
39,412.00
51,783.70
Non-Operating Interest Income
4.00
2.90
9.10
212.30
700.90
Preferred Dividends
1,076.30
1,580.70
4,356.40
-
-

About Edge Therapeutics

View Profile
Address
300 Connell Drive
Berkeley Heights New Jersey 07922
United States
Employees -
Website http://www.edgetherapeutics.com
Updated 09/14/2018
Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A.